Bertram KL - Search Results

1

Sodium selenate as a disease-modifying treatment for progressive supranuclear palsy: protocol for a phase 2, randomised, double-blind, placebo-controlled trial.

Vivash L, Bertram KL, Malpas CB, Marotta C, Harding IH, Kolbe S, Fielding J, Clough M, Lewis SJG, Tisch S, Evans AH, O'Sullivan JD, Kimber T, Darby D, Churilov L, Law M, Hovens CM, Velakoulis D, O'Brien TJ. Vivash L, et al. Among authors: bertram kl. BMJ Open. 2021 Dec 16;11(12):e055019. doi: 10.1136/bmjopen-2021-055019. BMJ Open. 2021. PMID: 34916328 Free PMC article.

2

Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial.

Höglinger GU, Litvan I, Mendonca N, Wang D, Zheng H, Rendenbach-Mueller B, Lon HK, Jin Z, Fisseha N, Budur K, Gold M, Ryman D, Florian H; Arise Investigators. Höglinger GU, et al. Lancet Neurol. 2021 Mar;20(3):182-192. doi: 10.1016/S1474-4422(20)30489-0. Lancet Neurol. 2021. PMID: 33609476 Clinical Trial.

3

Reversal of long term potentiation-like plasticity in primary motor cortex in patients with progressive supranuclear palsy.

Bologna M, Bertram K, Paparella G, Papi C, Belvisi D, Conte A, Suppa A, Williams DR, Berardelli A. Bologna M, et al. Clin Neurophysiol. 2017 Sep;128(9):1547-1552. doi: 10.1016/j.clinph.2017.06.032. Epub 2017 Jun 27. Clin Neurophysiol. 2017. PMID: 28704733 Clinical Trial.

4

Impact of prefrontal intermittent theta-burst stimulation on working memory and executive function in Parkinson's disease: A double-blind sham-controlled pilot study.

Hill AT, McModie S, Fung W, Hoy KE, Chung SW, Bertram KL. Hill AT, et al. Among authors: bertram kl. Brain Res. 2020 Jan 1;1726:146506. doi: 10.1016/j.brainres.2019.146506. Epub 2019 Oct 18. Brain Res. 2020. PMID: 31634450

5

Plasma Screening for Progranulin Mutations in Patients with Progressive Supranuclear Palsy and Corticobasal Syndromes.

Galimberti D, Bertram K, Formica A, Fenoglio C, Cioffi SM, Arighi A, Scarpini E, Colosimo C. Galimberti D, et al. J Alzheimers Dis. 2016 May 4;53(2):445-9. doi: 10.3233/JAD-160073. J Alzheimers Dis. 2016. PMID: 27163816

6

Safety and efficacy of botulinum toxin in primary orthostatic tremor.

Bertram K, Sirisena D, Cowey M, Hill A, Williams DR. Bertram K, et al. J Clin Neurosci. 2013 Nov;20(11):1503-5. doi: 10.1016/j.jocn.2012.12.025. Epub 2013 Aug 6. J Clin Neurosci. 2013. PMID: 23931935 Clinical Trial.

7

Visual hallucinations in the differential diagnosis of parkinsonism.

Bertram K, Williams DR. Bertram K, et al. J Neurol Neurosurg Psychiatry. 2012 Apr;83(4):448-52. doi: 10.1136/jnnp-2011-300980. Epub 2012 Jan 6. J Neurol Neurosurg Psychiatry. 2012. PMID: 22228724 Free PMC article. Review.

8

Levodopa-carbidopa intestinal gel: is the naso-jejunal phase a redundant convention?

Vijiaratnam N, Hewer S, Varley S, Paul E, Bertram KL, Lee W, Ligtermoet M, Williams DR. Vijiaratnam N, et al. Among authors: bertram kl. Intern Med J. 2018 Apr;48(4):469-471. doi: 10.1111/imj.13754. Intern Med J. 2018. PMID: 29623988

9

Serotonergic markers in Parkinson's disease and levodopa-induced dyskinesias.

Cheshire P, Ayton S, Bertram KL, Ling H, Li A, McLean C, Halliday GM, O'Sullivan SS, Revesz T, Finkelstein DI, Storey E, Williams DR. Cheshire P, et al. Among authors: bertram kl. Mov Disord. 2015 May;30(6):796-804. doi: 10.1002/mds.26144. Epub 2015 Feb 4. Mov Disord. 2015. PMID: 25649148

10

Treatment of camptocormia with botulinum toxin.

Bertram KL, Stirpe P, Colosimo C. Bertram KL, et al. Toxicon. 2015 Dec 1;107(Pt A):148-53. doi: 10.1016/j.toxicon.2015.06.004. Epub 2015 Jun 13. Toxicon. 2015. PMID: 26079953 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

31 results

Search Page